Related references
Note: Only part of the references are listed.Peripheral Role of Cathepsin S in Th1 Cell-Dependent Transition of Nerve Injury-Induced Acute Pain to a Chronic Pain State
Xinwen Zhang et al.
JOURNAL OF NEUROSCIENCE (2014)
Cathepsin S generates soluble CX3CL1 (fractalkine) in vascular smooth muscle cells
Ursa Pecar Fonovic et al.
BIOLOGICAL CHEMISTRY (2013)
Substituted 7-Amino-5-thio-thiazolo[4,5-d]pyrimidines as Potent and Selective Antagonists of the Fractalkine Receptor (CX(3)CR1)
Sofia Karlstrom et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Chloride extrusion enhancers as novel therapeutics for neurological diseases
Martin Gagnon et al.
NATURE MEDICINE (2013)
Neuron - glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage
GK Sheridan et al.
OPEN BIOLOGY (2013)
Neuropathic pain and cytokines: current perspectives
Anna K. Clark et al.
JOURNAL OF PAIN RESEARCH (2013)
Involvement of CX3CR1 in bone cancer pain through the activation of microglia p38 MAPK pathway in the spinal cord
Ji-Hua Hu et al.
BRAIN RESEARCH (2012)
Microglial signalling mechanisms: Cathepsin S and Fractalkine
Anna K. Clark et al.
EXPERIMENTAL NEUROLOGY (2012)
Gabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic rats
Jia-Le Yang et al.
MOLECULAR BRAIN (2012)
In vivo structure/function and expression analysis of the CX3C chemokine fractalkine
Ki-Wook Kim et al.
BLOOD (2011)
Fractalkine/CX3CR1 and atherosclerosis
Hong Liu et al.
CLINICA CHIMICA ACTA (2011)
Fractalkine/CX3CR1 Signalling in Chronic Pain and Inflammation
Anna K. Clark et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury
Praveen Anand et al.
EUROPEAN JOURNAL OF PAIN (2011)
Modulation of Peripheral Sensory Neurons by the Immune System: Implications for Pain Therapy
Christoph Stein et al.
PHARMACOLOGICAL REVIEWS (2011)
Overcoming hurdles in developing successful drugs targeting chemokine receptors
Thomas J. Schall et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Intrathecal injection of anti-CX3CR1 neutralizing antibody delayed and attenuated pain facilitation in rat tibial bone cancer pain model
Qin Yin et al.
BEHAVIOURAL PHARMACOLOGY (2010)
Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling
Gemma E. White et al.
CARDIOVASCULAR RESEARCH (2010)
Cathepsin S Release from Primary Cultured Microglia Is Regulated by the P2X7 Receptor
Anna K. Clark et al.
GLIA (2010)
Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice
Amelia A. Staniland et al.
JOURNAL OF NEUROCHEMISTRY (2010)
The neuro-immune balance in neuropathic pain: Involvement of inflammatory immune cells, immune-like glial cells and cytokines
Paul J. Austin et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Fractalkine/CX3CL1: A Potential New Target for Inflammatory Diseases
Brian A. Jones et al.
MOLECULAR INTERVENTIONS (2010)
Chemokines as Novel Therapeutic Targets for Inflammatory Bowel Disease
Miyuki Nishimura et al.
CONTEMPORARY CHALLENGES IN AUTOIMMUNITY (2009)
CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival
Limor Landsman et al.
BLOOD (2009)
The Liberation of Fractalkine in the Dorsal Horn Requires Microglial Cathepsin S
Anna K. Clark et al.
JOURNAL OF NEUROSCIENCE (2009)
P2X4-Receptor-Mediated Synthesis and Release of Brain-Derived Neurotrophic Factor in Microglia Is Dependent on Calcium and p38-Mitogen-Activated Protein Kinase Activation
Tuan Trang et al.
JOURNAL OF NEUROSCIENCE (2009)
Current Challenges in Glia-Pain Biology
Stephen B. McMahon et al.
NEURON (2009)
CX3CR1 Is Expressed by Human B Lymphocytes and Meditates CX3CL1 Driven Chemotaxis of Tonsil Centrocytes
Anna Corcione et al.
PLOS ONE (2009)
Activity of adenosine receptors type 1 is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons
Clotilde Lauro et al.
JOURNAL OF IMMUNOLOGY (2008)
Discovery of orally bioavailable cathepsin S inhibitors for the reversal of neuropathic pain
Osamu Irie et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Up-Regulation of P2X4 Receptors in Spinal Microglia after Peripheral Nerve Injury Mediates BDNF Release and Neuropathic Pain
Lauriane Ulmann et al.
JOURNAL OF NEUROSCIENCE (2008)
Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function
Yuko Ishida et al.
JOURNAL OF IMMUNOLOGY (2008)
Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior
Cedric Auffray et al.
SCIENCE (2007)
Role of the cysteine protease cathepsin S in neuropathic hyperalgesia
Jane Barclay et al.
PAIN (2007)
Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine
Zhi-Ye Zhuang et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain
Anna K. Clark et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes
Christian Hundhausen et al.
JOURNAL OF IMMUNOLOGY (2007)
An SCN9A channelopathy causes congenital inability to experience pain
James J. Cox et al.
NATURE (2006)
Mechanisms of Disease: neuropathic pain - a clinical perspective
R Baron
NATURE CLINICAL PRACTICE NEUROLOGY (2006)
BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain
JAM Coull et al.
NATURE (2005)
An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine
E Milligan et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity
C Limatola et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain
JA Lindia et al.
JOURNAL OF PAIN (2005)
Fractakine (CX3CL1) and fractakine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions
GM Verge et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats
ED Milligan et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
The disintegrin-like metalloproteinase ADAM 10 is involved in coinstitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion
C Hundhausen et al.
BLOOD (2003)
P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury
M Tsuda et al.
NATURE (2003)
Fractalkine protein localization and gene expression in mouse brain
G Tarozzo et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia-reperfusion brain injury in the rat
G Tarozzo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Tumor necrosis factor-α-converting enzyme mediates the inducible cleavage of fractalkine
CL Tsou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The clinical picture of neuropathic pain
TS Jensen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival
O Meucci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion
S Jung et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa
A Muehlhoefer et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
